Y-mAbs Therapeutics

Y-mAbs Therapeutics

  • Founded: 2014
  • Location: New York, NY
  • Employee range: 50 - 200
  • Clinical stage: COM
  • Therapy area: Neuroblastoma
  • Drug types: ONC, PED, VAC
  • Lead product: Danyelza (Naxitamab)
  • Product link: https://ymabs.com/research-development/pipeline/
  • Funding: $110M IPO Sep 2018; $50M Oct 2017



job board

Short description:

Antibody Therapies for Oncology

Drug notes:

Also 2 additional trials Clin2 neuroblastoma, Clin2 osteosarcoma; GD2-GD3 Clin2 neuroblastoma; Omburtamab 4 trials Clin1/Clin2 multiple cancers; GD2-SADA Clin1 multiple cancers; CD38-SADA Clin0 NHL

Long description:

Contact us to add description: recruit@workinbiotech.com


Y-mAbs Therapeutics
Senior Accountant
New Jersey, United States|14 days ago
Y-mAbs Therapeutics
Accounting Manager
New Jersey, United States|14 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com